All In Biotech

Investigational drug · Phase 3

MK-7240

Also called: PRA023, Tulisokibart

Not approved by FDA. In 10 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease.

Phase 3

Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 3

Industry-sponsored trials

Phase 2 and 3 trials

10

10 still active

All registered trials

15

Any phase or sponsor naming "MK-7240"

First trial start

2022

Mar 29, 2022

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "MK-7240", any sponsor or status.

Conditions studied

As listed on its trial records.

  • Ulcerative Colitis
  • Psoriatic Arthritis
  • Crohn's Disease
  • Diffuse Cutaneous Systemic Sclerosis
  • Interstitial Lung Disease
  • Radiographic Axial Spondyloarthritis
  • Pulmonary Sarcoidosis
  • Hidradenitis Suppurativa
  • Arthritis, Rheumatoid
  • Crohn Disease

Approved drugs for the same conditions: Psoriatic arthritis · Crohn's disease · Ulcerative colitis · Ankylosing spondylitis · Hidradenitis suppurativa · Immunology and inflammation

Largest trials

Live from ClinicalTrials.gov: studies naming "MK-7240" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 18 on PubMed

Also in development for Ulcerative Colitis

  • ZasocitinibTAK- 279, NDI-034858Phase 317 trials

    Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • DuvakitugSAR447189, TEV-48574 APhase 36 trials

    Sanofi · Ulcerative Colitis, Crohn's Disease, Hidradenitis

  • FilgotinibGS-6034, GLPG0634Phase 36 trials

    Alfasigma S.p.A. · Ulcerative Colitis, Polyarticular Course Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis (JIA)

  • ABX464ObefazimodPhase 35 trials

    Abivax S.A. · Ulcerative Colitis, Moderately to Severely Active Crohn Disease

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • MORF-057zotemtegrast, LY4268989Phase 24 trials

    Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) · Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis (UC)

  • ABBV-701Phase 22 trials

    AbbVie · Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do. More from Merck & Co..

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.